ResearchLetter to the Editor: Machine Learning Models for Screening Steatosis in MASLD: An International Validation Study
ResearchRacial and Gender Disparities in the Occurrence and Outcomes of Alcohol-Associated Hepatitis in Hospitalized Patients With Prior Bariatric Surgery
ResearchUsing Large Language Models to Predict Advanced Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Proof-of-Concept Analysis
ResearchCannabis Use Disorder Is Associated With Increased Risk of Acute Myocardial Infarction in Adults With Metabolic Dysfunction-Associated Steatohepatitis (MASH) Cirrhosis: A Population-Based Analysis
ResearchAI-Based Screening for At-Risk MASLD and Advanced Fibrosis in the US Population: A Cost-Effectiveness Analysis
ResearchEpigenetic reprogramming in metabolic dysfunction-associated steatotic liver disease: from metabolic memory to precision medicine
ResearchSemaglutide versus resmetirom for noncirrhotic MASH with moderate to advanced fibrosis: a cost-effectiveness analysis
ResearchMetabolic dysfunction-associated steatotic liver disease increases the risk of acute kidney injury in septic shock: A United States population-based study
ResearchOutcomes of GLP-1 receptor agonist therapy in adults with sickle cell disease and type 2 diabetes: a real-world cohort analysis
ResearchIncreased Cardiovascular and Cerebrovascular Events in Patients With Lean vs Non-lean MASLD: A Multicenter Analysis
ResearchFibroAgent: An Agentic AI Tool for Liver Fibrosis Screening and Clinical Decision Support in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)